(Q34152772)

31 July 2017

1 reference

title

Choice and use of newer anticonvulsant drugs in older patients (English)

1 reference

31 July 2017

Willmore LJ

1

1 reference

31 July 2017

publication date

1 December 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

441-452

1 reference

Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial

31 July 2017

cites work

1 reference

12 December 2020

Interference of oral phenytoin absorption by continuous nasogastric feedings

1 reference

12 December 2020

Pharmacokinetics of vigabatrin: implications of creatinine clearance

1 reference

12 December 2020

A survey of epileptic disorders in southwest France: seizures in elderly patients

1 reference

12 December 2020

Progress report on new antiepileptic drugs. A summary of the Second Eilat Conference

1 reference

12 December 2020

Hyponatremia induced by oxcarbazepine

1 reference

12 December 2020

Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

12 December 2020

Drug metabolism in the elderly

1 reference

12 December 2020

Metabolism of antiepileptic medication: newborn to elderly.

1 reference

12 December 2020

Importance of protein binding for the interpretation of serum or plasma drug concentrations

1 reference

12 December 2020

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

12 December 2020

Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Felbamate: a clinical trial for complex partial seizures

1 reference

12 December 2020

The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.

1 reference

12 December 2020

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

12 December 2020

Increased sensitivity to nitrazepam in old age

1 reference

12 December 2020

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

12 December 2020

Effect of felbamate on phenytoin and carbamazepine serum concentrations

1 reference

12 December 2020

Double-blind study of Gabapentin in the treatment of partial seizures.

1 reference

12 December 2020

Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics.

1 reference

12 December 2020

Antiepileptic drugs and alpha 1-acid glycoprotein

1 reference

12 December 2020

Anticonvulsant therapy in the elderly—A need for placebo controlled trials

1 reference

12 December 2020

Hyponatraemia during oxcarbazepine therapy

1 reference

12 December 2020

Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam.

1 reference

12 December 2020

How Common are Epileptic Seizures in Old Age?

1 reference

12 December 2020

The effect of age upon liver volume and apparent liver blood flow in healthy man.

1 reference

12 December 2020

Efficacy and safety of zonisamide: results of a multicenter study.

1 reference

12 December 2020

1 reference

12 December 2020

Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy

1 reference

12 December 2020

Protein binding drug displacement interactions fact or fiction?

1 reference

12 December 2020

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

12 December 2020

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

12 December 2020

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

12 December 2020

A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma

1 reference

12 December 2020

Late-onset epilepsy: etiologies, types of seizure, and value of clinical investigation, EEG, and computerized tomography scan.

1 reference

12 December 2020

Effect of age and sex on the plasma binding of acidic and basic drugs

1 reference

12 December 2020

Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

12 December 2020

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

1 reference

12 December 2020

The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine

1 reference

12 December 2020

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

12 December 2020

Gabapentin as an antiepileptic drug in man

1 reference

12 December 2020

1 reference

12 December 2020

Etiology of seizures in the elderly

1 reference

12 December 2020

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

12 December 2020

Adult experience with lamotrigine

1 reference

12 December 2020

Seizure disorders: the changes with age.

1 reference

12 December 2020

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

1 reference

12 December 2020

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

12 December 2020

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

1 reference

12 December 2020

Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine?

1 reference

12 December 2020

Advanced Alzheimer's disease is a risk factor for late-onset seizures

1 reference

12 December 2020

Clinical pharmacology of new antiepileptic drugs

1 reference

12 December 2020

1 reference

12 December 2020

(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier

1 reference

12 December 2020

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

12 December 2020

Gabapentin in partial epilepsy. UK Gabapentin Study Group

1 reference

12 December 2020

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

12 December 2020

Measured versus estimated creatinine clearance in a high-functioning elderly sample: MacArthur Foundation Study of Successful Aging.

1 reference

12 December 2020

Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy

1 reference

12 December 2020

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00002512-200017060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1018928155

0 references

1 reference